orcid-journal-Alzheimer-s-Dementia Journal

Overview
Identity
View All

publication venue for

Sharing health care wishes among older adults with cognitive impairment in primary care: Results from a randomized controlled trial.. 20:7263-7273. 2024
Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementias 2024
Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementias 2024
Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer′s Disease Study (LEADS) 2023
Amyloid and tau‐PET in early‐onset AD: Baseline data from the Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) 2023
Amyloid‐, tau‐, and FDG‐PET in amyloid‐negative patients clinically diagnosed with early‐onset Alzheimer’s disease in the LEADS study 2023
Amyloid‐, tau‐, and FDG‐PET in amyloid‐negative patients clinically diagnosed with early‐onset Alzheimer’s disease in the LEADS study 2023
Amyloid‐PET, tau‐PET, and their association in sporadic early‐onset Alzheimer’s Disease: Cross‐sectional and longitudinal data from the LEADS study 2023
Comparison of Expert Reads vs. Local Clinical Reads of Amyloid PET Scans in IDEAS 2023
Comparison of Expert Reads vs. Local Clinical Reads of Amyloid PET Scans in IDEAS 2023
Perceptions about Dementia Clinical Trials 2023
Quantitative Amyloid‐PET in Real‐World Practice: Lessons from the Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) study 2023
Regional patterns of pathological tau accumulation in sporadic early‐onset Alzheimer’s disease: Longitudinal tau‐PET in the LEADS Cohort 2023
The development and refinement of the enhancing active caregiver training (EnACT) intervention for caregivers of persons living with dementia 2023
Towards the future of ADRD diagnosis: combination of a brief digital cognitive battery and plasma biomarkers for diagnosis and prognosis of disease 2023
18F‐MK‐6240 Tau PET as a Biomarker for Chronic Traumatic Encephalopathy: Case Series of 10 Symptomatic Former National Football League Players 2022
Amyloid Negative, Highly Tau Positive: Clinical Characterization of a Rare Biomarker Profile 2022
Quantitative analysis of 6,150 real‐world amyloid Positron Emission Tomography (PET) scans from the Imaging Dementia–Evidence for Amyloid Scanning (IDEAS) study 2022
Comparison of plasma and CSF biomarkers across ethnoracial groups in ADNI 2021
Early detection of dementia and mild cognitive impairment with BrainCheck 2021
Education differentially contributes to cognitive reserve across racial/ethnic groups 2021
IDEAS and New IDEAS: Amyloid PET in diverse populations 2021
VALIDATION STUDY OF THE GERMAN VERSION OF MONTREAL COGNITIVE ASSESSMENT (MOCA) 2019
GERMAN NORMATIVE DATA FOR THE MONTREAL COGNITIVE ASSESSMENT 2018
Standardisation of a novel self-administered screening tool for postoperative delirium: a prospective observational study 2017
Dexmedetomidine versus propofol-remifentanil based conscious sedation during awake craniotomy for supratentorial tumor resection: a prospective, double-blind, randomized trial 2015
Monitored anesthesia care during awake craniotomy: a prospective, double-blind, randomized trial comparing the intraoperative use of dexmedetomidine and propofol-remifentanil 2015
P3‐493: EFFECT OF AGING AND EDUCATION ON LEXICAL PRODUCTION TASKS IN HEALTHY OLDER ADULTS: A LONGITUDINAL STUDY 2006
Machine learning of transcripts and audio recordings of spontaneous speech for diagnosis of Alzheimer’s disease 2021
Validation study of the German version of the Montreal Cognitive Assessment (MoCA) 2019
Differences in normative samples of the Montreal Cognitive Assessment: Call for guidelines 2018
German normative data for the Montreal Cognitive Assessment (MoCA) 2018
German normative data for the Montreal Cognitive Assessment (MoCA) 2018
Predictors of postoperative delirium in patients undergoing cardiac surgery 2017
Predictors of postoperative delirium in patients undergoing cardiac surgery 2017
Standardisation of a novel self-administered screening tool for postoperative delirium: a prospective observational study 2017
Standardisation of a novel self-administered screening tool for postoperative delirium: a prospective observational study 2017
Dexmedetomidine versus propofol-remifentanil based conscious sedation during awake craniotomy for supratentorial tumor resection: a prospective, double-blind, randomized trial 2015
Monitored anesthesia care during awake craniotomy: a prospective, double-blind, randomized trial comparing the intraoperative use of dexmedetomidine and propofol-remifentanil 2015